Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells

Journal Article · · Proceedings of the National Academy of Sciences of the United States of America; (USA)
; ;  [1];  [2];  [3]
  1. Memorial Hospital of Rhode Island, Pawtucket (USA) Brown Univ. Program in Medicine, Providence, RH (USA)
  2. Memorial Hospital of Rhode Island, Pawtucket (USA)
  3. Brown Univ. Program in Medicine, Providence, RI (USA)
Erythropoietin is known to be a hematopoietic growth factor with a singularly specific action on the proliferation and differentiation of erythroid progenitor cells. The authors have observed a dose-dependent proliferative action of human recombinant erythropoietin on human umbilical vein endothelial cells and bovine adrenal capillary endothelial cells. Binding studies with radioiodinated recombinant human erythropoietin revealed a large number ({approx}27,000) of an apparent single class of receptors with an affinity in the 10{sup {minus}9} M range. Linkage of the radiolabeled ligand to its receptor via a bifunctional crosslinking agent allowed them to identify an endothelial cell protein of 45 kDa as the principal receptor associated with this mitogenic effect of erythropoietin. Recombinant human erythropoietin also enhanced the migration of endothelial cells.
OSTI ID:
6214107
Journal Information:
Proceedings of the National Academy of Sciences of the United States of America; (USA), Journal Name: Proceedings of the National Academy of Sciences of the United States of America; (USA) Vol. 87:15; ISSN 0027-8424; ISSN PNASA
Country of Publication:
United States
Language:
English